Document is current
Any future updates will be listed below
-
Authors
Ndiaye, Yaye D.
Wong, Wesley
Thwing, Julie
Schaffner, Stephen F.
Brenneman, Katelyn Vendrely
Tine, Abdoulaye
Diallo, Mamadou A.
Deme, Awa B.
Sy, Mouhamad
Bei, Amy K.
Thiaw, Alphonse B.
Daniels, Rachel
Ndiaye, Tolla
Gaye, Amy
Ndiaye, Ibrahima M.
Toure, Mariama
Gadiaga, Nogaye
Sene, Aita
Sow, Djiby
Garba, Mamane N.
Yade, Mamadou S.
Dieye, Baba
Diongue, Khadim
Zoumarou, Daba
Ndiaye, Aliou
Gomis, Jules F.
Fall, Fatou B.
Ndiop, Medoune
Diallo, Ibrahima
Sene, Doudou
Macinnis, Bronwyn
Seck, Mame C.
Ndiaye, Mouhamadou
Ngom, Bassirou
Diedhiou, Younouss
Mbaye, Amadou M.
Ndiaye, Lamine
Sy, Ngayo
Badiane, Aida S.
Hartl, Daniel L.
Wirth, Dyann F.
Volkman, Sarah K.
Ndiaye, Daouda
-
Funding
Funding for this research was provided by:
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
NIH/ICEMR (U19AI089696)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
Bill and Melinda Gates Foundation (Investment ID 0PP1200177 and Investment ID INV-004036)
- License Information
-
More Information
Article History
Received: 17 April 2024
Accepted: 25 June 2024
First Online: 9 July 2024
Declarations
:
: The study was reviewed and approved by the Ministry of Health and Social Action in Senegal (Protocol SEN14/49) and the Institutional Review Board at Harvard T.H. Chan School of Public Health (CR-16330-07). This study was registered at the Pan African Clinical Trials Registry on 09 March 2020 under the number PACTR 202003802011316.
: The findings and conclusions in this paper are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention. The authors declare no competing of interests.
